November 7, 2013 — The U.S. Department of Veteran Affairs has awarded a multi-million dollar, five-year contract to a Rutgers University-based research partnership to conduct a first-of-its kind genotyping study to improve the health of veterans.
The contract, valued at $7.5 million in the first year and undisclosed afterward, will be handled by the BioProcessing Solutions Alliance, a partnership consisting of RUCDR Infinite Biologics, a Busch Campus biorepository that collects and stores biological materials for investigation, and private company BioStorage Technologies. Read the rest of this entry »
New Brunswick, NJ, November 7, 2013 —Rutgers Business School’s MBA in Pharmaceutical Management has been recognized as one of the top 10 MBA programs for Health Care/Pharmaceuticals/Biotechnology in the world, according to Find-MBA.com.
Concentrating on business schools that would best help MBA grads land internships and jobs focused in health care, pharmaceuticals and biotechnology, Rutgers Business School drew praise for being “close to big pharma companies like Johnson & Johnson and Bristol-Myers Squibb, as well as several large hospitals.”
Read more here.
New Brunswick, NJ, November 7, 2013 — The Cambridge Crystallographic Data Centre (CCDC) and the Center for Integrative Proteomics Research (CIPR) at Rutgers, The State University of New Jersey, announce that they have formed a new public-private partnership, which sees the CCDC establish operations in North America housed within the CIPR alongside the RCSB Protein Data Bank. Coincident with formation of this new partnership is the launch of CCDC Inc., which will serve the CCDC’s user communities across North America.
The new CCDC organization will collaborate with scientists at the RCSB Protein Data Bank and the CIPR to develop and implement new integrated approaches to scientific discovery, working closely with academic and industrial partners. Read the rest of this entry »
New Brunswick, NJ, November 6, 2013 — On November 1, Christopher J. Molloy, Ph.D., who led the Rutgers-UMDNJ integration, assumed his new role the Rutgers’ senior vice president for research and economic development.
Dr. Molloy’s responsibilities include oversight and strategic planning for the university’s $700 million in annual research expenditures and management of the many institutional offices and resources that support Rutgers’ research and economic development activities. Read the rest of this entry »